
Percutaneous coronary intervention using sirolimus eluting balloons in patients at high bleeding risk - The SELUTION DeNovo HBR sub-study
5.10.2026
0:00
15:54
In this episode of Editor’s Choice, Dr Aaysha Cader and Dr Philip Urban discuss the findings of SELUTION DeNovo HBR, comparing SEB versus DES PCI strategies.
Dr Urban describes the dual-risk profile of the enrolled HBR patients and shares the hypothesis-generating results including 1-year TVF, BARC 3+ bleeding, and NACE rates which favoured the balloon arm – possibly linked to lower use of antiplatelet therapy in SEB-treated patients.
Hosted on Acast. See acast.com/privacy for more information.
Więcej odcinków z kanału "EuroIntervention | Editor's Choice"



Nie przegap odcinka z kanału “EuroIntervention | Editor's Choice”! Subskrybuj bezpłatnie w aplikacji GetPodcast.








